Visual Overview
Abstract
The metabotropic glutamate 5 receptor and the cannabinoid type 1 receptor are G protein–coupled receptors that are widely expressed in the central nervous system. Metabotropic glutamate 5 receptors, present at the postsynaptic site, are coupled to Gαq/11 proteins and display an excitatory response upon activation, whereas the cannabinoid type 1 receptor, mainly present at presynaptic terminals, is coupled to the Gi/o protein and triggers an inhibitory response. Recent studies suggest that the glutamatergic and endocannabinoid systems exhibit a functional interaction to modulate several neural processes. In this review, we discuss possible mechanisms involved in this crosstalk and its relationship with physiologic and pathologic conditions, including nociception, addiction, and fragile X syndrome.
Footnotes
- Received March 21, 2016.
- Accepted June 16, 2016.
I.G.O. and T.H.F.-V. contributed equally to this work.
This research was supported by the Fundação de Amparo a Pesquisa do Estado de Minas Gerais and the Conselho Nacional de Desenvolvimento Científico e Tecnológico.
- Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|